<DOC>
	<DOCNO>NCT00812071</DOCNO>
	<brief_summary>Dose escalation study : 3 dose group . 5 patient dose group , 15 patient `` best '' group . 3 vaccination volunteer , 0 6 16 week .</brief_summary>
	<brief_title>Phase 1B Study RiVax , Vaccine Prevent Toxic Effects Ricin</brief_title>
	<detailed_description>Final report submit Dr. Karen Russell FDA , Rockville September 26 , 2012 .</detailed_description>
	<criteria>healthy volunteer age 1831 , f immunodeficiency pregnant chronic disease parental IgG abnormal lab drug use hiv hep c hep b</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>31 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>volunteer</keyword>
</DOC>